According to Longeveron's latest financial reports the company's current EPS (TTM) is -$0.95. In 2022 the company made an earnings per share (EPS) of -$0.90 a decrease over its 2021 EPS that were of -$0.89.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.95 | 5.56% |
2022 | -$0.90 | 1.12% |
2021 | -$0.89 | 290.03% |
2020 | -$0.23 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 129.47% | ๐บ๐ธ USA |